Oppenheimer Upgrades AngioDynamics (NASDAQ:ANGO) to Outperform

Oppenheimer upgraded shares of AngioDynamics (NASDAQ:ANGO – Free Report) from a market perform rating to an outperform rating in a report released on Friday morning, Marketbeat Ratings reports. Oppenheimer currently has $12.00 price target on the medical instruments supplier’s stock. ANGO has been the subject of a number of other research reports. Raymond James decreased […]

Related Keywords

United States ,Raymond James ,Jamesc Clemmer ,Sg Capital Management ,Angiodynamics Inc ,Acadian Asset Management ,Angiodynamics Company Profile ,Jacobs Levy Equity Management Inc ,Barclays Plc ,Free Report ,Marketbeat Ratings ,Moderate Buy ,Get Free Report ,Asset Management ,Levy Equity Management ,Auryon Atherectomy ,Angiodynamics Daily ,